RxDoctor Payments DataLook up a doctor →

Daniel Soteres, MD

Allergy · Colorado Springs, CONPI 1679573588

Payments from drug & device makers

$5,020,777in general payments, 2019–2025

Across 2,146 payments — averaging $2339.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.5M
  • Takeda Pharmaceuticals U.S.A., Inc.$695K
  • AstraZeneca$677K
  • Teva Pharmaceuticals USA, Inc.$377K
  • Biocryst Pharmaceuticals, Inc.$189K
  • Sanofi US Services Inc.$179K
  • plus $1.4M from 39 others
$30in research payments, 2019–2025

Across 1 payment — averaging $29.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$30

What the payments were for

  • Consulting fees$230,79336%
  • Speaking & faculty fees$343,83353%
  • Travel & lodging$43,4087%
  • Food & beverage$31,8755%
  • Education$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$164,654
Medicare patients
160
Services billed
7,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TakhzyroLanadelumab-Flyo38$1,576,186
OrladeyoBerotralstat Hydrochloride12$558,215
IcatibantIcatibant Acetate14$182,202
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5022$58,079
XolairOmalizumab21$41,168
NucalaMepolizumab11$40,689
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$36,355
Spiriva RespimatTiotropium Bromide17$17,865
SymbicortBudesonide/Formoterol Fumarate48$17,730
Breo ElliptaFluticasone/Vilanterol15$9,306
Advair DiskusFluticasone Propion/Salmeterol13$4,558
Arnuity ElliptaFluticasone Furoate12$3,313
Wixela InhubFluticasone Propion/Salmeterol16$2,962
Albuterol Sulfate HfaAlbuterol Sulfate50$1,511
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Takhzyro$695,006$1,576,18638 claims
Biocryst US Sales Co., LLCOrladeyo$85,380$558,21512 claims
GSKNucala, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta$1,144$89,66378 claims
CSL BehringPrivigen$59,491$58,07922 claims
Genentech, Inc.Xolair$128,125$41,16821 claims
Boehringer IngelheimSpiriva Respimat$134$17,86517 claims
AstraZenecaSymbicort$676,657$17,73048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Coloradoon file to place this against a meaningful peer group, so we don't.

Other allergy in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →